Exact Mass: 428.2046
Exact Mass Matches: 428.2046
Found 500 metabolites which its exact mass value is equals to given mass value 428.2046
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Austalide L
Austalide L is a mycotoxin produced by Aspergillus ustu
Taraxacolide 1-O-b-D-glucopyranoside
*Constituent of Taraxacum officinale (dandelion). Taraxacolide 1-O-b-D-glucopyranoside is found in many foods, some of which are coffee and coffee products, beverages, alcoholic beverages, and tea. Taraxacolide 1-O-b-D-glucopyranoside is found in alcoholic beverages. *Taraxacolide 1-O-b-D-glucopyranoside is a constituent of Taraxacum officinale (dandelion
Pyridinoline
Derived from collagen cross-links formed between adjacent hydroxylysine residues in type I and type II collagen of bone and cartilage respectively. Released into serum during bone resorption Pyridinoline is a breakdown product of bone collagen. It can be used as a bone marker to measure osteoclastic activity.
1-(3-(4-Phenylbenzyl)-4-hydroxychroman-7-yl)cyclopentane-1-carboxylic acid
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists
Xanthine amine congener
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
Hypochoeroside A
Hypochoeroside a belongs to germacranolides and derivatives class of compounds. Those are sesquiterpene lactones with a structure based on the germacranolide skeleton, characterized by a gamma lactone fused to a 1,7-dimethylcyclodec-1-ene moiety. Hypochoeroside a is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Hypochoeroside a can be found in endive, which makes hypochoeroside a a potential biomarker for the consumption of this food product.
Isomajdine
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids Annotation level-1
Sphaeranthanolide
Sonchuside F
Sonchuside G
11beta,13-dihydroparthenolide-14-O-beta-D-glucopyranoside
(E,E)-3beta-O-beta-D-glucopyranosyl-9beta-hydroxy-6beta,7alpha,11betaH-germacra-1(10),4-dien-12,6-olide|scorzoaustriacoside
4alpha,5alpha-epoxy-10alpha,11beta,13H,14H-1-epi-inuviscolide 3-beta-D-glucoside
(5-angeloyloxytiglinoyloxy)-costunolide|<5-angeloyloxytiglinoyloxy>-costunolide
(2R,4S)-2-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-2,4-pentanediol
(1R,2S,4S,5R,6R,9S)-2-hydroxy-11-oxoallocedra-13-oic acid 13-O-beta-D-glucopyranosyl ester
14-O-beta-D-glucopyranosyl-6-deoxy-3,4-dehydrofloridanolide|dunnianolide A
1-(2-Amino-1-oxopropyl)-2,3,3alpha, 13alpha, 14,15,16,18alpha-octahydro-8-methoxy-5,9-metheno-9H-dipyrrolo[3,2-b:1,2-e][1,5,8]oxadiazacyclopentadecine-13,18-(1H,12H)-dione
(19S)-17,19-epoxy-10,11-dimethoxy-7-oxo-1,7-dihydro-(20alphaH)-2xi,6-cyclo-6,7-seco-coryn-16-ene-16-carboxylic acid methyl ester|(2S,3S,15S,19S,20S)-isoreserpiline pseudoindoxyl|10,11-dimethoxy-19alpha-methyl-7-oxo-1,7-dihydro-(20alpha)-18-oxa-2xi,6-cyclo-6,7-seco-yohimb-16-ene-16-carboxylic acid methyl ester|Isoreserpilin-pseudoindoxyl|Isoreserpilin-Psi-indoxyl|isoreserpiline pseudoindoxyl
1beta-[(E-p-methoxycinnamoyl)oxy]-6alpha-hydroxyisodrimeninol
4alpha-hydroxy-5alpha,8betaH-eudesman-7(11)-en-8alpha,12-olide-15-O-beta-D-glucopyranoside|sarcaglaboside H
3beta-hydroxy-4aH-3-dihydrosantamarine-1beta-D-glucopyranoside
CAY10594
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
Isocarapanaubine
(2R,2R,4aS,6R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalen]-6-yl acetate
((S)-2-((E)-6-((R)-3,3-dimethyloxiran-2-yl)-4-methylhex-3-en-1-yl)-8-formyl-5-hydroxy-2-methyl-2H-chromen-7-yl)methyl acetate
Majdine
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, Secologanin typtamine alkaloids, Indole alkaloids
Elegantine
Origin: Plant; Formula(Parent): C23H28N2O6; Bottle Name:Isomajdine; PRIME Parent Name:Isomajdine; PRIME in-house No.:V0302; SubCategory_DNP: Alkaloids derived from tryptophan, Secologanin typtamine alkaloids, Indole alkaloids PRIME Parent Name:Isomajdine; Origin: Plant; Formula(Parent): C23H28N2O6; Bottle Name:Isomajdine; PRIME in-house No.:V0302; SubCategory_DNP: Alkaloids derived from tryptophan, Secologanin typtamine alkaloids, Indole alkaloids
Ala Ala His Met
Ala Ala Met His
Ala Cys His Val
Ala Cys Val His
Ala His Ala Met
Ala His Cys Val
Ala His Met Ala
Ala His Thr Thr
Ala His Val Cys
Ala Met Ala His
Ala Met His Ala
Ala Asn Pro Gln
Ala Asn Gln Pro
Ala Pro Asn Gln
Ala Pro Gln Asn
Ala Gln Asn Pro
Ala Gln Pro Asn
Ala Thr His Thr
Ala Thr Thr His
Ala Val Cys His
Ala Val His Cys
Cys Ala His Val
Cys Ala Val His
Cys Gly His Ile
Cys Gly His Leu
Cys Gly Ile His
Cys Gly Leu His
Cys His Ala Val
Cys His Gly Ile
Cys His Gly Leu
Cys His Ile Gly
Cys His Leu Gly
Cys His Val Ala
Cys Ile Gly His
Cys Ile His Gly
Cys Ile Pro Pro
Cys Leu Gly His
Cys Leu His Gly
Cys Leu Pro Pro
Cys Pro Ile Pro
Cys Pro Leu Pro
Cys Pro Pro Ile
Cys Pro Pro Leu
Cys Val Ala His
Cys Val His Ala
Asp Pro Pro Thr
Asp Pro Thr Pro
Asp Thr Pro Pro
Glu Pro Pro Ser
Glu Pro Ser Pro
Glu Ser Pro Pro
Gly Cys His Ile
Gly Cys His Leu
Gly Cys Ile His
Gly Cys Leu His
Gly His Cys Ile
Gly His Cys Leu
Gly His Ile Cys
Gly His Leu Cys
Gly Ile Cys His
Gly Ile His Cys
Gly Leu Cys His
Gly Leu His Cys
Gly Pro Gln Gln
Gly Gln Pro Gln
Gly Gln Gln Pro
His Ala Ala Met
His Ala Thr Thr
His Cys Ala Val
His Cys Gly Ile
His Gly Ile Cys
His Gly Leu Cys
His Ile Cys Gly
His Ile Gly Cys
His Leu Cys Gly
His Leu Gly Cys
His Met Ala Ala
His Ser Ser Val
His Ser Val Ser
His Thr Ala Thr
His Thr Thr Ala
His Val Ala Cys
His Val Cys Ala
His Val Ser Ser
Ile Cys Gly His
Ile Cys His Gly
Ile Cys Pro Pro
Ile Gly Cys His
Ile Gly His Cys
Ile His Cys Gly
Ile His Gly Cys
Ile Pro Cys Pro
Ile Pro Pro Cys
Leu Cys Gly His
Leu Cys His Gly
Leu Cys Pro Pro
Leu Gly Cys His
Leu Gly His Cys
Leu His Cys Gly
Leu His Gly Cys
Leu Pro Cys Pro
Leu Pro Pro Cys
Met Ala Ala His
Met Ala His Ala
Met His Ala Ala
Asn Ala Pro Gln
Asn Ala Gln Pro
Asn Pro Ala Gln
Asn Pro Gln Ala
Asn Gln Ala Pro
Asn Gln Pro Ala
Pro Ala Asn Gln
Pro Ala Gln Asn
Pro Cys Ile Pro
Pro Cys Leu Pro
Pro Cys Pro Ile
Pro Cys Pro Leu
Pro Asp Pro Thr
Pro Asp Thr Pro
Pro Glu Pro Ser
Pro Glu Ser Pro
Pro Gly Gln Gln
Pro Ile Cys Pro
Pro Ile Pro Cys
Pro Leu Cys Pro
Pro Leu Pro Cys
Pro Asn Ala Gln
Pro Asn Gln Ala
Pro Pro Cys Ile
Pro Pro Cys Leu
Pro Pro Asp Thr
Pro Pro Glu Ser
Pro Pro Ile Cys
Pro Pro Leu Cys
Pro Pro Ser Glu
Pro Pro Thr Asp
Pro Gln Ala Asn
Pro Gln Gly Gln
Pro Gln Asn Ala
Pro Gln Gln Gly
Pro Ser Glu Pro
Pro Ser Pro Glu
Pro Thr Asp Pro
Pro Thr Pro Asp
Gln Ala Asn Pro
Gln Ala Pro Asn
Gln Gly Pro Gln
Gln Gly Gln Pro
Gln Asn Ala Pro
Gln Asn Pro Ala
Gln Pro Ala Asn
Gln Pro Gly Gln
Gln Pro Asn Ala
Gln Pro Gln Gly
Gln Gln Gly Pro
Gln Gln Pro Gly
Ser Glu Pro Pro
Ser His Ser Val
Ser His Val Ser
Ser Pro Glu Pro
Ser Pro Pro Glu
Ser Ser His Val
Ser Ser Val His
Ser Val His Ser
Ser Val Ser His
Thr Ala His Thr
Thr Ala Thr His
Thr Asp Pro Pro
Thr His Ala Thr
Thr His Thr Ala
Thr Pro Asp Pro
Thr Pro Pro Asp
Thr Thr Ala His
Thr Thr His Ala
Val Ala Cys His
Val Ala His Cys
Val Cys Ala His
Val Cys His Ala
Val His Ala Cys
Val His Cys Ala
Val His Ser Ser
Val Ser His Ser
Val Ser Ser His
Austalide L
Taraxacolide 1-O-b-D-glucopyranoside
9beta-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
9alpha-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
(S)-N-(2-HYDROXY-2-METHYL-1-PHENYL-PROPYL)-4-METHYL-BENZENESULFONAMIDE
1H-Azepine,hexahydro-1-[[[1-[2-(4-methyl-1-piperidinyl)-2-oxoethyl]-1H-benzimidazol-2-yl]thio]acetyl]-(9CI)
Pregna-1,4-dien-21-al, 16,17-[butylidenebis(oxy)]-11-hydroxy-3,20-dioxo-, (11β,16α)
L-Tyrosine,N-[(phenylmethoxy)carbonyl]-L-valyl-, methyl ester
5-O-tert-Butyldiphenylsilyl-2,3-O-isopropylidene-D-ribofuranose
2,2-azobis[2-[1-(2-hydroxyethyl)-2-imidazolin-2-yl]propane] dihydrochloride monohydrate
8-(4-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-3-(6-METHYLPYRIDIN-2-YL)-1H-PYRAZOL-1-YL)-2-OXASPIRO[4.5]DECAN-1-ONE
1H-Benzimidazole-1-acetamide,N-cyclopentyl-2-[[2-(2,6-dimethyl-1-piperidinyl)-2-oxoethyl]thio]-(9CI)
Olmesartan lactone impurity
Olmesartan lactone impurity is a cyclic ester impurity of Olmesartan. Olmesartan is an angiotensin II receptor (AT1R) antagonist and has the potential for high blood pressure study[1][2].
ADL5859 HCl
ADL-5859 hydrochloride (compound 20) is a selective and orally active δ opioid receptor (DOR) agonist with an Ki and an EC50 value of 0.84 and 20 nM, respectively. ADL-5859 hydrochloride also shows inhibitory activity to hERG channel with an IC50 value of 78 μM. ADL-5859 hydrochloride can be used for the research of pain[1][2].
butanedioic acid,sulfo-,4-dodecyl 1-(2-propenyl)ester,sodium salt
Dopexamine hydrochloride
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Dopexamine hydrochloride is a β2 adrenergic receptor agonist.
pseudoephedrine sulfate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
Ephedrine sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
N-[2-(2,4-Diaminopyrido[2,3-D]pyrimidin-7-Yl)-2-Methylpropyl]-4-Phenoxybenzamide
9-Cyclopentyl-6-[2-(3-imidazol-1-YL-propoxy)-phenylamino]-9H-purine-2-carbonitrile
N-[2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl]naphthalene-2-carboxamide
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
N(2)-[3-methoxy-4-(morpholin-4-yl)phenyl]-N(4)-(quinolin-3-yl)pyrimidine-2,4-diamine
Methyl (1S,4aS,5aR,6R,10aS)-6,7-dimethoxy-1-methyl-2-oxospiro[1,4a,5,5a,7,8,10,10a-octahydropyrano[3,4-f]indolizine-6,3-1H-indole]-4-carboxylate
2-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]-oxomethyl]-1,5-dimethyl-4-pyrrolo[3,2-c]quinolinone
[4-[2-(4-Methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-(3-pyridinyl)methanone
N-[2-(2-benzamidoethyl)-1-methyl-5-benzimidazolyl]-2-methoxybenzamide
2-(4-methyl-N-(4-methylphenyl)sulfonylanilino)-N-[(1-methyl-4-piperidinylidene)amino]acetamide
N-(3-fluoro-4-methylphenyl)-4-[3-(4-methyl-1-piperidinyl)propylamino]-3-nitrobenzamide
11-{[(E)-furan-2-ylmethylidene]amino}-3-hexyl-2-methyl-3,11-dihydro-4H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4-one
[(2S,3R)-6-(1,3-benzodioxol-5-ylmethyl)-3-phenyl-1-(phenylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
N-(cyclohexylmethyl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
1-[(3aS,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(2S,3R)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(2-pyridinyl)ethanone
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
N-(cyclohexylmethyl)-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
[(3aR,4R,9bR)-8-(1-cyclohexenyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
1-[(3aR,4S,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(3aR,4R,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(2S,3S)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(2-pyridinyl)ethanone
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
2-[[(2R)-2-(8-carboxyoctanoyloxy)-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-(8-carboxyoctanoyloxy)-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
methyl (1S,6R)-6,7-dimethoxy-1-methyl-2-oxospiro[1,4a,5,5a,7,8,10,10a-octahydropyrano[3,4-f]indolizine-6,3-1H-indole]-4-carboxylate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] dodecanoate
(2-hydroxy-3-phosphonooxypropyl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
GSK2194069
GSK2194069 is a potent inhibitor of β-ketoyl reductase (KR) of fatty acid synthase (FASN), with an IC50 value of 7.7 nM. GSK2194069 shows specifically inhibitory effect on FAS expressing cancer cells, by acting potent efficacy on acetoacetyl-CoA, NADPH with IC50 or Ki values of 4.8 nM and 5.6 nM, respectively[1][2][3].
3,4a,5-trimethyl-6-[(2-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
(4ar,5r,8ar,9as)-5-hydroxy-3,8a-dimethyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4h,4ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(1s,2r,4r,7z,11s,12s)-4,12-dimethyl-8-({[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-13-one
(3s,3as,9r,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(3s,3ar,4ar,5s,6r,7ar,9ar)-5-hydroxy-3,5,8-trimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,4ah,6h,7h,7ah,9ah-azuleno[6,5-b]furan-2-one
(3s,3as,5ar,6r,9s,9as,9bs)-3,5a,9-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-naphtho[1,2-b]furan-2,8-dione
(3s,3as,9s,11ar)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
19-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
(3s,3ar,4s,6s,7r,7as)-6-ethenyl-4-hydroxy-3,6-dimethyl-7-[(1e)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl]-hexahydro-1-benzofuran-2-one
3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
3,5a-dimethyl-2-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydronaphtho[1,2-b]furan-9-carbaldehyde
9-(hydroxymethyl)-5a-methyl-3-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-2-one
20-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
5,9a-dihydroxy-5b,9,9,11a-tetramethyl-2-(penta-1,3-dien-1-yl)-5,5a,6,7,10,11-hexahydro-1,12-dioxatetraphene-4,8-dione
(3s,3as,9s,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
6-ethenyl-4-hydroxy-3,6-dimethyl-7-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-hexahydro-1-benzofuran-2-one
methyl (1's,3r,4'as,5'as,10'as)-2-hydroxy-6,7-dimethoxy-1'-methyl-1',4'a,5',5'a,7',8',10',10'a-octahydrospiro[indole-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate
(4s,4ar,5r,6s,8as)-3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl (2z)-2-methylbut-2-enoate
2-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
10-({4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic acid
(3s,3ar,4s,6ar,8s,9s,9ar,9br)-4-hydroxy-3,9-dimethyl-6-methylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydroazuleno[4,5-b]furan-2-one
20r,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003438","Ingredient_name": "20r,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7189","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20s,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003472","Ingredient_name": "20s,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C)OC=O","Ingredient_weight": "428.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7190","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101244896","DrugBank_id": "NA"}